These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24022492)

  • 21. Real-time monitoring of trans-epithelial electrical resistance in cultured intestinal epithelial cells: the barrier protection of water-soluble dietary fiber.
    Majima A; Handa O; Naito Y; Suyama Y; Onozawa Y; Higashimura Y; Mizushima K; Morita M; Uehara Y; Horie H; Iida T; Fukui A; Dohi O; Okayama T; Yoshida N; Kamada K; Katada K; Uchiyama K; Ishikawa T; Takagi T; Konishi H; Yasukawa Z; Tokunaga M; Okubo T; Itoh Y
    J Dig Dis; 2017 Mar; 18(3):151-159. PubMed ID: 28139083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel disease.
    Spalinger MR; McCole DF; Rogler G; Scharl M
    World J Gastroenterol; 2016 Jan; 22(3):1034-44. PubMed ID: 26811645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative regulation of interferon-γ/STAT1 signaling through cell adhesion and cell density-dependent STAT1 dephosphorylation.
    Chen Z; Ma X; Zhang H; Sun X; Shen S; Li Y; Gu Y; Wang Y; Yan S; Yu Q
    Cell Signal; 2011 Aug; 23(8):1404-12. PubMed ID: 21511030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein tyrosine phosphatase N2 regulates TNFα-induced signalling and cytokine secretion in human intestinal epithelial cells.
    Scharl M; McCole DF; Weber A; Vavricka SR; Frei P; Kellermeier S; Pesch T; Fried M; Rogler G
    Gut; 2011 Feb; 60(2):189-97. PubMed ID: 21115548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase.
    Mattila E; Marttila H; Sahlberg N; Kohonen P; Tähtinen S; Halonen P; Perälä M; Ivaska J
    BMC Cancer; 2010 Jan; 10():7. PubMed ID: 20055993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AMP-activated protein kinase mediates the interferon-gamma-induced decrease in intestinal epithelial barrier function.
    Scharl M; Paul G; Barrett KE; McCole DF
    J Biol Chem; 2009 Oct; 284(41):27952-27963. PubMed ID: 19654324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein tyrosine phosphatase nonreceptor type 2 regulates autophagosome formation in human intestinal cells.
    Scharl M; Wojtal KA; Becker HM; Fischbeck A; Frei P; Arikkat J; Pesch T; Kellermeier S; Boone DL; Weber A; Loessner MJ; Vavricka SR; Fried M; McCole DF; Rogler G
    Inflamm Bowel Dis; 2012 Jul; 18(7):1287-302. PubMed ID: 21987459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin.
    Youakim A; Ahdieh M
    Am J Physiol; 1999 May; 276(5):G1279-88. PubMed ID: 10330020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction.
    Wang F; Schwarz BT; Graham WV; Wang Y; Su L; Clayburgh DR; Abraham C; Turner JR
    Gastroenterology; 2006 Oct; 131(4):1153-63. PubMed ID: 17030185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-gamma modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding.
    Adams RB; Planchon SM; Roche JK
    J Immunol; 1993 Mar; 150(6):2356-63. PubMed ID: 8450217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role for protein tyrosine phosphatase nonreceptor type 2 in regulating autophagosome formation.
    Scharl M; Rogler G
    Ann N Y Acad Sci; 2012 Jun; 1257():93-102. PubMed ID: 22671594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superantigen immune stimulation activates epithelial STAT-1 and PI 3-K: PI 3-K regulation of permeability.
    McKay DM; Botelho F; Ceponis PJ; Richards CD
    Am J Physiol Gastrointest Liver Physiol; 2000 Nov; 279(5):G1094-103. PubMed ID: 11053007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cell type-specific role of protein tyrosine phosphatase non-receptor type 2 in regulating ER stress signalling.
    Kasper SH; Spalinger MR; Raselli T; Scharl M
    Digestion; 2015; 91(3):248-56. PubMed ID: 25823847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein tyrosine phosphatases PTP-1B and TC-PTP play nonredundant roles in macrophage development and IFN-gamma signaling.
    Heinonen KM; Bourdeau A; Doody KM; Tremblay ML
    Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9368-72. PubMed ID: 19474293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting palmitoyl acyltransferase ZDHHC21 improves gut epithelial barrier dysfunction resulting from burn-induced systemic inflammation.
    Haines RJ; Wang CY; Yang CGY; Eitnier RA; Wang F; Wu MH
    Am J Physiol Gastrointest Liver Physiol; 2017 Dec; 313(6):G549-G557. PubMed ID: 28838985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3.
    Simoncic PD; Lee-Loy A; Barber DL; Tremblay ML; McGlade CJ
    Curr Biol; 2002 Mar; 12(6):446-53. PubMed ID: 11909529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abrogation of IFN-gamma mediated epithelial barrier disruption by serine protease inhibition.
    Willemsen LE; Hoetjes JP; van Deventer SJ; van Tol EA
    Clin Exp Immunol; 2005 Nov; 142(2):275-84. PubMed ID: 16232214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-γ alters downstream signaling originating from epidermal growth factor receptor in intestinal epithelial cells: functional consequences for ion transport.
    Paul G; Marchelletta RR; McCole DF; Barrett KE
    J Biol Chem; 2012 Jan; 287(3):2144-55. PubMed ID: 22069319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction.
    Demaude J; Salvador-Cartier C; Fioramonti J; Ferrier L; Bueno L
    Gut; 2006 May; 55(5):655-61. PubMed ID: 16299034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells.
    Fischer A; Gluth M; Pape UF; Wiedenmann B; Theuring F; Baumgart DC
    Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G970-9. PubMed ID: 23538493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.